Pliant Therapeutics, Inc.
PLRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$210,304 | -$161,336 | -$123,321 | -$97,263 |
| Dep. & Amort. | $2,125 | $1,841 | $1,823 | $1,535 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $37,626 | $44,483 | $22,598 | $10,437 |
| Change in WC | $9,089 | $1,251 | $4,217 | $6,917 |
| Other Non-Cash | $5,961 | -$2,600 | $52 | $2,931 |
| Operating Cash Flow | -$155,503 | -$116,361 | -$94,631 | -$75,443 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,848 | -$921 | -$1,760 | -$1,953 |
| Net Acquisitions | $0 | $0 | $148,444 | -$75,652 |
| Inv. Purchases | -$211,285 | -$583,069 | -$325,716 | -$219,887 |
| Inv. Sales/Matur. | $355,473 | $456,978 | $177,272 | $295,539 |
| Other Inv. Act. | $0 | $0 | -$148,444 | $75,652 |
| Investing Cash Flow | $140,340 | -$127,012 | -$150,204 | $73,699 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $19,910 | $0 | $10,000 | $0 |
| Stock Issued | $3,207 | $275,252 | $215,644 | $2,984 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$847 | $1,210 | -$457 |
| Financing Cash Flow | $23,117 | $274,405 | $226,854 | $2,527 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $7,954 | $31,032 | -$17,981 | $783 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $64,716 | $33,684 | $51,665 | $50,882 |
| End Cash | $72,670 | $64,716 | $33,684 | $51,665 |
| Free Cash Flow | -$159,351 | -$117,282 | -$96,391 | -$77,396 |